On December 24, 2021, Abpro Bio Co., Ltd. closed the transaction. The company amended the terms of the transaction and issued 7,159,904 shares at a price of KRW 838 for gross proceeds of KRW 5,999,999,552. The transaction involved participation from returning investor Veritas Fund.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
501 KRW | 0.00% | -1.96% | -8.07% |
1st Jan change | Capi. | |
---|---|---|
-8.07% | 105M | |
+70.89% | 4.27B | |
+3.17% | 2.04B | |
+7.34% | 2.02B | |
-4.85% | 1.95B | |
-10.74% | 1.47B | |
+16.58% | 1.41B | |
-8.37% | 1.33B | |
-27.21% | 1.33B | |
-16.74% | 1.25B |
- Stock Market
- Equities
- A195990 Stock
- News Abpro Bio Co., Ltd.
- Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding